The Latest Dose
Ep. 9: The Prix Galien – Honoring Pharmaceutical Research and Development for 50 Years

Ep. 9: The Prix Galien – Honoring Pharmaceutical Research and Development for 50 Years

October 23, 2020

Every year, the brightest minds in pharmaceuticals and clinical innovation put on their best black-tie attire for the life science industry’s biggest event, the Prix Galien. In this episode, you’ll learn about the history of the Prix Galien Awards, why it is considered the “Nobel Prize” for pharmaceutical research and development, and find out the new additions to its program from its chair and co-chair, Bruno Cohen and Dr. Michael Rosenblatt.

Ep. 8: Embracing the Future of Decentralized Trials and Remote Visits for Site Staff and Patients

Ep. 8: Embracing the Future of Decentralized Trials and Remote Visits for Site Staff and Patients

October 21, 2020

The pandemic heavily disrupted clinical trials, pushing us to rethink how we conduct clinical research. In this episode, Kathy invites Casey Orvin, SVP of pharmaceutics relationships at StudyKIK and honorary president of SCRS to talk about the future of decentralized trials and remote visits from the patient and site perspective.

 

 

Ep. 7: The Role of AI, Automation, and Touchless Case Processing in Patient Safety

Ep. 7: The Role of AI, Automation, and Touchless Case Processing in Patient Safety

August 27, 2020

In episode seven of The Latest Dose, our host Kathy Vandebelt invites two of Oracle’s safety experts, Vice President of Safety Product Strategy, Bruce Palsulich, and Senior Director of Safety Strategy, Michael Braun-Boghos, to explore areas in pharmacovigilance where AI, automation, and touchless case processing are having a significant and positive impact on managing patient safety.

 

Ep. 6: Embracing Biometric Monitoring Technologies and Digital Measurement in Clinical Research

Ep. 6: Embracing Biometric Monitoring Technologies and Digital Measurement in Clinical Research

July 24, 2020

In this episode, host Kathy Vandebelt discusses how to get comfortable with the use of mobile technologies in clinical trials with our guest, Jennifer GoldSack. Jen serves as the Executive Director of the Digital Medicine Society (DiMe). She was also an Olympic athlete, and ties in her experience in the Olympics with the topic at hand – biometric monitoring.

Ep. 5: Thanking the Clinical Trial Patient and Giving Back for the Greater Good

Ep. 5: Thanking the Clinical Trial Patient and Giving Back for the Greater Good

June 24, 2020

In this episode, our host Kathy Vandebelt brings back Greater Gift and PopUp Star Founder, Jennifer Byrne, to talk this time specifically about the importance of giving back to clinical trial participants. In this interview, Jennifer dives into what Greater Gift is, her motivation for founding it, why it’s important, and what they do to thank participants and other clinical research stakeholders.

Ep. 4: Celebrating Clinical Trials Day and Bringing Awareness to Clinical Research

Ep. 4: Celebrating Clinical Trials Day and Bringing Awareness to Clinical Research

May 19, 2020

For Clinical Trials Day, we want to shine a light on the patients and people who bring awareness to clinical research. To do this, Kathy Vandebelt interviews two industry veterans, Greater Gift and PopUp Star Founder Jennifer Bryne, and Oracle Health Sciences’ Senior VP and General Manager Steve Rosenberg, about their personal experiences with clinical research, the history of Clinical Trials Day, what PopUp Star is, and how it's bringing awareness to clinical research.

Ep. 3: Considering the Patient & Improving the Clinical Research Ecosystem

Ep. 3: Considering the Patient & Improving the Clinical Research Ecosystem

February 6, 2020

Kathy Vandebelt speaks with Joe Kim, Eli Lilly & Company’s Sr. Advisor, Digital Health Office, and host of Lilly’s podcast Elixir Factor, which explores the factors that inspire bold advances in science. He aims to improve the capabilities for one of humankind's biggest social issues - the development of new medicine. Hear Joe’s opinions on approaches, initiatives, & technology to make clinical research more patient-friendly.

Ep. 2: Unifying the Old and New – How “Virtual” Components are Changing Clinical Trials

Ep. 2: Unifying the Old and New – How “Virtual” Components are Changing Clinical Trials

February 6, 2020

In this episode, Host Kathy Vandebelt discusses decentralized trials with Dylan Rosser, Executive Director of Global Development Operations at Amgen. Dylan brings to light the various virtual components that are used and can be stitched together in a trial. He also talks about the importance of the patient in clinical research, and highlights the benefits decentralized trials can bring to them.

Ep. 1: Improving Clinical Research: Go it Alone, or Join Industry-Driven Initiatives?

Ep. 1: Improving Clinical Research: Go it Alone, or Join Industry-Driven Initiatives?

February 4, 2020

In this episode, Oracle Health Sciences Global Head of Innovation, Kathy Vandebelt, speak with Allergan's Director of Global Study Start Up and Essential Documents, Lorena Gomez, about TransCelerate and her role since the beginning. Tune in to hear her opinions about industry initiatives, insights into the Shared Investigator Platform program, and what she thinks they should work on next.

Play this podcast on Podbean App